Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Post by Stockspawkon Apr 12, 2018 11:42pm
241 Views
Post# 27877475

Today

TodayJust my thoughts....

She's down a few cents today, but the one thing I notice on this SH forum; versus the vast majority of other SH forums, is the class. She did go down, but the there isn't 9,897 daily comments about how there are shorts, longs, insiders, bashers, pumpers etc. who are munipulating the stock price. I am a fairly new stock investor who has done their DD on investing, and in my honest opinion, I feel that we are all on track for a very rewarding return. This isnt going to happen overnight as this is something that the big pharma community was not prepared when the results came out. Big pharma too has to do their own DD. It only makes sense. I am not one to look at charts on a daily basis and my mentality is "set it and forget it!". I am very confident with the strategic approach that ATB has taken with their board members and their wanting to branch out to get the best people on board to make this a true game changer. I'm long, strong and hoping we will all being singing a finacial song, in the future.

This company, in my opinion, is truley going to be a game changer. 


Bullboard Posts